Dr. Kwentus is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3531 Lakeland Drive
Suite 1060 Brentwood Plaza
Flowood, MS 39232Phone+1 601-420-5810
Education & Training
OtherClass of 2011
MedStar Health/Georgetown University HospitalResidency, Neurology, 1980 - 1982
National Capital ConsortiumResidency, Psychiatry, 1973 - 1975
Washington University/B-JH/SLCH ConsortiumInternship, Transitional Year, 1972 - 1973
Saint Louis University School of MedicineClass of 1972
Certifications & Licensure
MO State Medical License 1972 - 2025
MS State Medical License 2002 - 2025
CA State Medical License 1976 - 2024
LA State Medical License 1991 - 2024
TN State Medical License 1991 - 2024
VA State Medical License 1979 - 2024
WA State Medical License 1990 - 2024- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Addiction Psychiatry
- American Board of Psychiatry and Neurology Forensic Psychiatry
- American Board of Psychiatry and Neurology Geriatric Psychiatry
- American Board of Psychiatry and Neurology Pain Medicine
- American Board of Psychiatry and Neurology Sleep Medicine
- American Board of Preventive Medicine Addiction Medicine
- American Board of Psychiatry and Neurology Consultation-Liaison Psychiatry
- Join now to see all
Clinical Trials
- Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen® Start of enrollment: 2014 Jun 01
Roles: Contact, Principal Investigator
- OXD01 in Combination With Sublingual Buprenorphine/Naloxone for Treatment of Opioid Use Disorder Start of enrollment: 2021 Jun 30
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 69 citationsRapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo-controlled clinical trial with inhaled loxapine.Joseph Kwentus, Robert A. Riesenberg, Morteza Marandi, Raymond A Manning, Michael H. Allen
Bipolar Disorders. 2012-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
